Long-Term results of liver transplantation

Scandinavian Journal of Surgery

Volumn 100, Issue 1, 2011, Pages 14-21

  Aberg F ^a   Isoniemi, H ^a   Hockerstedt K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cancer; Cardiovascular; Employment; Graft dysfunction; Liver transplantation; Malignancy; Morbidity; Mortality; Quality of life; Renal dysfunction

Indexed keywords

EID: 79952906629     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691110000104     Document Type: Article

References (48)

1. Nordic Liver Transplant Group. 2010; Available at: http://www.scandiatransplant.org/. Accessed October, 2010
2. European Liver Transplant Registry. 2010; Available at: http://www.eltr.org. Accessed October, 2010
3. Neuberger J, James O: Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999;354:1636-1639
4. Benten D, Staufer K, Sterneck M: Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol 2009; 6:23-36
5. McGuire BM, Rosenthal P, Brown CC, et al: Long-term management of the liver transplant patient: recommendations for the primary care doctor. Am J Transplant 2009;9:1988-2003
6. Wiesner RH, Demetris AJ, Belle SH, et al: Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998;28:638-645
7. Pruthi J, Medkiff KA, Esrason KT, et al: Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001;7:811-815
8. Barber K, Blackwell J, Collett D, et al: Life expectancy of adult liver allograft recipients in the UK. Gut 2007;56:279-282
9. Åberg F, Koivusalo AM, Höckerstedt K, et al: Renal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic disease. Transpl Int 2007;20:591-599
10. Pham PT, Pham PC, Wilkinson AH: Management of renal dysfunction in the liver transplant recipient. Curr Opin Organ Transplant 2009;14:231-239
11. Ojo AO, Held PJ, Port FK, et al: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349: 931-940
12. Gonwa TA, Mai ML, Melton LB, et al: End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001;72:1934-1939
13. Cohen AJ, Stegall MD, Rosen CB, et al: Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002;8:916-921
14. Pillebout E, Nochy D, Hill G, et al: Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005;5:1120-1129
15. Mells G, Neuberger J: Long-term care of the liver allograft recipient. Semin Liver Dis 2009;29:102-120
16. Farkas SA, Schnitzbauer AA, Kirchner G, et al: Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009;22:49-60
17. Neuberger JM, Mamelok RD, Neuhaus P, et al: Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT'study. Am J Transplant 2009;9:327-336
18. Ciccarelli O, Kaczmarek B, Roggen F, et al: Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation. Acta Gastroenterol Belg 2005;68:323-330
19. Johnston SD, Morris JK, Cramb R, et al: Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002;73:901-906
20. Reuben A: Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 2001;7:S13-21
21. Åberg F, Jula A, Höckerstedt K, et al: Cardiovascular risk profile of patients with acute liver failure after liver transplantation when compared with the general population. Transplantation 2010;89:61-68
22. Sheiner PA, Magliocca JF, Bodian CA, et al: Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000;69:781-789
23. Moon JI, Barbeito R, Faradji RN, et al: Negative impact of newonset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006;82:1625-1628
24. Lerut J, Bonaccorsi-Riani E, Finet P, et al: Minimization of steroids in liver transplantation. Transpl Int 2009;22:2-19
25. Åberg F, Pukkala E, Höckerstedt K, et al: Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008;14:1428-1436
26. Herrero JI: De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl 2009;15 Suppl 2:S90-4
27. Sint Nicolaas J, de Jonge V, Steyerberg EW, et al: Risk of colo rectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant 2010;10:868-876
28. Miao Y, Everly JJ, Gross TG, et al: De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 2009;87:1347-1359
29. Finkenstedt A, Graziadei IW, Oberaigner W, et al: Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant 2009;9:2355-2361
30. Buell JF, Gross TG, Woodle ES: Malignancy after transplantation. Transplantation 2005;80:S254-64
31. Loren AW, Porter DL, Stadtmauer EA, et al: Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003;31:145-155
32. Opelz G, Dohler B: Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004;4:222-230
33. Opelz G, Daniel V, Naujokat C, et al: Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. Lancet Oncol 2007;8:212-218
34. Herrero JI, Alegre F, Quiroga J, et al: Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009;23:532-536
35. Drent G, De Geest S, Dobbels F, et al: Symptom experience, nonadherence and quality of life in adult liver transplant recipients. Neth J Med 2009;67:161-168
36. Desai M, Neuberger J: Chronic liver allograft dysfunction. Transplant Proc 2009;41:773-776
37. Kotlyar DS, Campbell MS, Reddy KR: Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol 2006;101:1370-1378
38. Gautam M, Cheruvattath R, Balan V: Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006;12:1813-1824
39. Rowe IA, Webb K, Gunson BK, et al: The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 2008;21:459-465
40. Hubscher SG: Transplantation pathology. Semin Liver Dis 2009;29:74-90
41. Burra P, Senzolo M, Adam R, et al: Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010;10: 138-148
42. Sharma S, Gurakar A, Jabbour N: Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl 2008;14:759-769
43. Uemura T, Ikegami T, Sanchez EQ, et al: Late acute rejection after liver transplantation impacts patient survival. Clin Transplant 2008;22:316-323
44. Åberg F, Rissanen AM, Sintonen H, et al: Health-related quality of life and employment status of liver transplant patients. Liver Transpl 2009;15:64-72
45. Tome S, Wells JT, Said A, et al: Quality of life after liver transplantation. A systematic review. J Hepatol 2008;48:567-577
46. Bownik H, Saab S: Health-related quality of life after liver transplantation for adult recipients. Liver Transpl 2009;15 Suppl 2:S42-49
47. Sahota A, Zaghla H, Adkins R, et al: Predictors of employment after liver transplantation. Clin Transplant 2006;20:490-495
48. Demetris AJ: Evolution of hepatitis C virus in liver allografts. Liver Transpl 2009;15 Suppl 2:S35-41